Impact of Anti-tumor Necrosis Factor (Anti-TNF) Therapy on Cardiovascular Risk in Patients With Ankylosing Spondylitis

Anti-TNF therapy significantly improves inflammatory, lipid, and vascular parameters, thereby reducing CV risk in patients with AS.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-08-28
DOI
https://doi.org/10.7759/cureus.91185
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Anti-tumor Necrosis Factor (Anti-TNF) Therapy on Cardiovascular Risk in Patients With Ankylosing Spondylitis

Ahsan Amer, Farzana Hakim, Ahmed Amer, A E Ahmed Amer
1 links
Cureus
Spondyloarthritis Studies and Treatments
article

Impact of Anti-tumor Necrosis Factor (Anti-TNF) Therapy on Cardiovascular Risk in Patients With Ankylosing Spondylitis

Ahsan Amer, Farzana Hakim, Ahmed Amer, A E Ahmed Amer
article en

Abstract

Anti-TNF therapy significantly improves inflammatory, lipid, and vascular parameters, thereby reducing CV risk in patients with AS.

CureusVol. 17(8)
Foundation University Islamabad (PK), Pakistan Army (PK), Royal Bournemouth Hospital (GB), Foundation University Medical College (PK), Pakistan Institute of Medical Sciences (PK)
Good health and well-being
Openalex Percentile: Top 66%
Spondyloarthritis Studies and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.